Sign In
Buy CMPGY
$32.39
+0.120 (+0.372%)
At Close: Jun 03, 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
CMPGY or CMG: Which Is the Better Value Stock Right Now?
12:01am, Tuesday, 04'th Nov 2025
Investors interested in Retail - Restaurants stocks are likely familiar with Compass Group PLC (CMPGY) and Chipotle Mexican Grill (CMG). But which of these two stocks offers value investors a better b
Compass Diversified Announces Extension of Credit Agreement Forbearance
04:10pm, Monday, 03'rd Nov 2025
WESTPORT, Conn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI”) announced today that its senior secured lender group has extended to November 10, 2025 the due date for
Compass Therapeutics to Participate in Upcoming November Investor Events
08:00am, Monday, 03'rd Nov 2025
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based
Is Webster Financial a Buy After Investment Firm Compass Wealth Made the Stock Its Top Holding?
04:36pm, Sunday, 02'nd Nov 2025
Investment firm Compass Wealth acquired 96,518 shares of Webster Financial for an estimated $31.8 million in the third quarter. This is a new position in Webster Financial for Compass Wealth Managemen
Compass Minerals International, Inc. (NYSE:CMP) Receives $20.00 Consensus Target Price from Brokerages
03:19am, Friday, 31'st Oct 2025
Shares of Compass Minerals International, Inc. (NYSE: CMP - Get Free Report) have earned an average recommendation of "Reduce" from the five ratings firms that are presently covering the stock, Market
NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression
08:30am, Thursday, 30'th Oct 2025
Collaboration will leverage AI-powered neural analysis and Compass' expertise in psychedelic drug development to advance new therapies for mental health KEARNY, N.J. , Oct. 30, 2025 /PRNewswire/ -- Ne
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Compass (CODI) To Contact Him Directly To Discuss Their Options If you purchased or acqu
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors
06:30am, Wednesday, 29'th Oct 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025
06:30am, Tuesday, 28'th Oct 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Meta Platforms, Inc. $META Shares Acquired by Compass Advisory Group LLC
06:38am, Sunday, 26'th Oct 2025
Compass Advisory Group LLC increased its holdings in shares of Meta Platforms, Inc. (NASDAQ: META) by 3.7% during the second quarter, according to its most recent disclosure with the Securities and Ex
Compass to Announce Third Quarter 2025 Results Before Market Open on November 4
07:00am, Thursday, 16'th Oct 2025
NEW YORK , Oct. 16, 2025 /PRNewswire/ -- Compass, Inc. (NYSE: COMP), the largest residential real estate brokerage in the United States 1 and leading tech-enabled real estate services company, announc
CMPGY vs. CAVA: Which Stock Is the Better Value Option?
12:41pm, Wednesday, 15'th Oct 2025
Investors with an interest in Retail - Restaurants stocks have likely encountered both Compass Group PLC (CMPGY) and Cava Group (CAVA). But which of these two stocks is more attractive to value invest
Compass Diversified: Rare Earths Bottleneck An Odd Catalyst As Financials Remain Elusive
08:47am, Wednesday, 15'th Oct 2025
Compass Diversified's ownership of Arnold Magnetic Technologies ("AMT"), a high-performance permanent magnet manufacturer, has helped its common shares gain exposure to the rare earths trade. AMT was
Compass Lexecon Adds Antitrust and Finance Expertise with Two Senior Hires
07:30am, Monday, 13'th Oct 2025
WASHINGTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Compass Lexecon, a subsidiary of FTI Consulting, Inc. (NYSE: FCN), today announced the appointments of Dr. Jeremy Verlinda as an Executive Vice President
